Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘lymphoma’

February 16th, 2017

Drug combo safe for diffuse large B-cell lymphoma

By Nicole Brudos Ferrara nicoleferrara

  Drugs targeting the P13K-mTOR pathway add benefit when combined with standard R-CHOP therapy.   The drug everolimus can be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma, according to the results of a pilot study by Mayo Clinic researchers. The researchers published their study findings in the July 2016 issue of […]

View full entry · Comment on this

Tags: diffuse large B-cell lymphoma, Dr Patrick Johnston, everolimus, Forefront, lymphoma, Mayo Clinic Cancer Center, non-Hodgkin lymphoma, R-CHOP


December 9th, 2010

Translocations in T-cell lymphoma: A first

By

A Mayo research team recently scored a first that garnered some valuable information regarding biomarkers for T-cell lymphoma, a fatal condition that has a 60 to 70 percent mortality rate. The up side is that this discovery may lead to therapeutic targets for future study, once the findings published in the journal Blood are validated. […]

View full entry · Comment on this


Contact Us · Privacy Policy